Treatment landscape and disease burden of patients with multiple myeloma in Japan: a real-world surveyFUTURE ONCOLOGYIF2.62025-02-040OAAI
Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in EuropeFUTURE ONCOLOGYIF2.62023-09-142OA
Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USAFUTURE ONCOLOGYIF2.62023-06-075OA
Frequency and impact of retreatment in relapsed refractory multiple myeloma (RRMM): Real-world survey conducted in 5 European countries (United Kingdom, France, Germany, Italy, Spain)ANNALS OF ONCOLOGYIF65.42022-09-010PRE